• Journal of Oral Medicine and Pain
• /
• 제30권4호
• /
• pp.427-432
• /
• 2005

본 연구는 구강안면통증 환자의 음성적 특징과 청각 환경에 따른 음성적 변화를 살펴보기 위한 것이다. 구강안면통증 환자 29명과 정상인 31명을 대상으로 그들의 일반 음성과 청각 조건(소음, 음악)에서의 음성 파라미터들을 비교 분석하여 다음과 같은 결론을 얻을 수 있었다. 1. 구강안면통증 환자는 정상인의 음성과 비교해 낮은 F0(Hz) 값과 높은 jitter(%), shimmer(%)값을 가져 정상인에 비해 낮고 불안정한 음성 특징(feature)을 나타내었다. 2. 구강안면통증 환자의 음성은 소음 환경과 비교해 음악 환경에서 낮은 F0(Hz)값과 shimmer(%)값을 가져 보다 이완되고 안정된 음성 특징을 나타내었다. 3. 정상인의 음성은 소음 환경에서 높은 F0(Hz)값을 가졌으나 음악, 소음 환경에 따른 특징적인 차이를 나타내지 않았다. 이상의 결과를 통해 구강안면통증 환자는 정상인의 음성과 비교해 특징적인 차이를 보였으며 외부적인 청각 환경에도 다른 반응 양상을 나타내었다. 따라서 구강안면통증 환자들의 기능적 장애를 보다 효율적으로 치료하기 위해서는 음악과 같은 긍정적인 정서 환경이 제공되어야 할 것으로 사료된다.

• 동의신경정신과학회지
• /
• 제20권3호
• /
• pp.65-88
• /
• 2009

Objectives : There has not been the comparison research of medication on the Insomnia as the complementary significance of the Oriental-Western Cooperative Therapeutic Viewpoint so far. The aim of this preliminary research is to study Eastern and Western Medication Model for the Insomnia through the comparison of Oriental Medication based on "Sang Han Lon" and "Dong yui bo gam". Methods : The author researched oriental-western viewpoints and the present treatment condition of Sleep and Sleeping Pills with reference to Korean articles issued since 1975, dissertations, journals registered or candidated on KCI, alternative medicine journals on Pubmed, and books concerning Neuropsychiatry. In the field of Oriental medical study, this study was demonstrated on "The Oriental Medical textbook of neuropsychiatry", "Sang han lon", "Dong yui bo gam" and the present research trend. Results : In Oriental Medicine, Insomnia is treated according to si-jie-bu-shui-zung (思結不睡證) type, rong-xie-bu-zu-zung (榮血不足證) type, yin-her-nae-re-zung (陰虛內熱證) type, xin-dan-her-qie-zung (心膽虛怯證) type, dam-xian-yu-jie-zung (痰涎鬱結證) type, and wei-zhong-bu-he-zung (胃中不和證) type etc. In Western Medicine, Insomnia has been treated by Barbiturate over 60's and BZ over 70's. According to recent treatment on Insomnia, Zolpidem or Zaleplon, which is short-lived and has less side effects, is used much, and tri-cyclic antidepressants are prescribed on a chronic psycho-physiological insomnia. Conclusions : Generally, Insomnia is being treated by controlling whole ways. The oriental medication is less effective for sleep induction. On the contrary, that of western medication is very effective for sleep induction, but there are many possibilities of side effects. If this two mutual therapy is conducted cooperatively, more effective medical care might be expected. Therefore, it is considered that not only the oriental medical study for sleep induction, but the study of Oriental-Western Cooperative Therapy should be preceded to treat Insomnia from now on.

• KSBB Journal
• /
• 제30권6호
• /
• pp.283-290
• /
• 2015

In this study was selected the cellulolytic microorganism and investigated optimum condition of cellulase production for the cellulosic bioethanol production. A bacterial strain Paenibacillus jamilae BRC15-1, was isolated from soil of domestic reclaimed land. For optimizing cellulase production from the selected strain, various culture parameters were investigated such as culture medium, pH (pH 4~10), temperature ($25{\sim}50^{\circ}C$) and culture time (2~72 h). As a result, P. jamilae BRC15-1 efficiently produced cellulase from cellulosic biomass under following conditions: 24 h of culture time (pH 7, $40^{\circ}C$) in manufactured media of CMC (carboxymethyl cellulose) with peptone. Optimum saccharifying condition of crude enzyme produced from P. jamilae BRC15-1 was identified on pH 6 and $40^{\circ}C$ of reaction temperature, respectively. This crude enzyme from P. jamilae BRC15-1 was used for saccharification of pretreated sweet sorghum (Sorghum bicolor var. dulciusculum Ohwi) bagasse under the optimal condition. Finally, pretreated sweet sorghum bagasse including 0.1 g of glucan was saccharified by crude enzyme of P. jamilae BRC15-1 into 2.75 mg glucose, 0.79 mg xylose and 1.12 mg arabinose.

• 한국축산식품학회지
• /
• 제29권4호
• /
• pp.523-532
• /
• 2009

Changing health awareness has had an important effect on the functional food industry and is creating greater market opportunities. Unfortunately, there is no statement on functional dairy products in the Processing of Livestock Products Act. As a result, there is confusion in the market and legal difficulties with regard to the advertising of functional dairy products. This study was carried out to improve the current standardization of functional dairy products by comparing the domestic Health/Functional Food Act with the Japanese Health Promotion Law, and by investigating scientific data and articles from various literature and the Internet. In Japan, the Ministry of Health, Labor, and Welfare (MHLW) officially presented the Food with Health Claims (FHC) system that consists of Food with Nutrient Function Claims (FNFC), and innovated Food for Specified Health Uses (FOSHU). In 2005, the FOSHU system was changed to include several new subsystems: Current, Standardized, Reduction of disease risk, and Qualified FOSHU. Finally, to manufacture FOSHU, scientific evidence pertaining to such products must be examined by MHLW. Since FNFC was allowed, only 12 vitamins, ${\beta}-carotene$, and five minerals were approved, though without scientific evidence of efficacy. The Korean Health/Functional Food Act requires that health/functional foods (HFFs) be marketed in measured doses. There are two types of HFFs: generic and product-specific. There are 67 ingredients listed in the act for generic HFFs, and if an HFF has a new active ingredient, it is considered a product-specific HFF. Product-specific HFFs must be approved by the Korean Food and Drug Administration (KFDA). With the present standards, it is impossible to label and advertise functional dairy products with health/functional claims. Government agencies must cooperate to solve this problem, and standardization should be carried out by considering existing health/functional products and claims/indications from other countries.

• 대한한방내과학회지
• /
• 제23권2호
• /
• pp.165-173
• /
• 2002

Purpose : Among numerous biological symptoms of cancer, matrix metalloproteinases (MMPs) are essential for tumor invasion and metastasis. HAD is used as an inhibitor of MMP gene. This study was designed to evaluate the effects of HAD on anti metastasis and preventing recurrence in cancer patients. Materials and Methods : We retrospectively analyzed the medical records of 69 cancer patients who had been administered with HAD for over 12 months continuously in East-West Cancer Center of Oriental Hospital of Daejeon University, from January 1993 to May 2002. Results : We analyzed gender, portion, stage and anti-metastasis & recurrence rates of cancer patients. Analysis of sex cases showed that the percentage of male is 62.3%, female is 37.7%. Analysis of cancer portion showed that the percentage of stomach is 31.9%, colorectum is 26.1%, lung is 21.7%, liver is 8.7%, breast is 8.7% Analysis of stage showed that the rate of III is 78.3%, IV is 13.0% and II is 8.7%. Analysis of anti-metastasis and recurrence rates showed that colorectal cancer is 77.8%, stomach cancer is 63.6%, lung cancer is 33.4% and breast cancer is 33.3% (mean : 53.6%). Conclusions : HAD has significant effects on anti-metastasis and preventing recurrence of tumor on cancer patients. So it helps to prolong the survival rates of cancer patients.

• 한국미생물·생명공학회지
• /
• 제9권2호
• /
• pp.71-75
• /
• 1981

Trichoderma sp. KI 7-2와 내열성 효모를 이용하여 볏짚에서 ethanol을 생산하기 위한 동시당화-발효의 최적조건을 검토하였다. 발효생산시 고체배양에서의 배지는 밀기울과 볏짚을 3 : 2 로 혼합하고 pH를 4.5로 조절한 수분함량 50%의 고체배지에서 7일간 배양한 koji를 사용했을 때 가장 높은 ethanol이 생산되었다. 기질의 전처리는 ethanol 생산성에 영향을 미치지 않는 것으로 나타났다. 볏짚의 동시당화-발효를 위해서는 효소량은 볏짚 1g당 2.47units가 요구되며, 발효액중 초기 효모 농도가 2.5$\times$$10^{7}$ cell/$m\ell$이면 충분하였다. 동시당화-발효 과정을 위한 최적 pH와 온도는 각각 4.5와 4$0^{\circ}C$였다. 또한 동시당화-발효액에 다시 기질 또는 효소와 기질을 첨가하여 최종 ethanol 농도를 높일 수 있었다.

• 한국식품위생안전성학회지
• /
• 제32권1호
• /
• pp.50-56
• /
• 2017

본 연구는 약수와 약수터 음용도구의 일반세균수, 대장균군수 및 식중독세균 오염도를 평가하여 약수와 음용도구의 미생물학적 안전성을 평가하고자 하였다. 약수터 10곳의 약수와 약수터에 비치되어 있는 음용도구 34건을 실험대상으로 하였다. 약수의 경우 일반세균수는 평균 1.8 log CFU/mL 검출되었고 음용도구의 경우 평균 $4.7log\;CFU/100cm^2$ 검출되었다. 위생지표미생물인 대장균군의 경우 약수는 평균 1.2 log CFU/mL 검출되었고 음용도구는 평균 $1.7log\;CFU/100cm^2$ 검출되었다. B. cereus, S. aureus, Salmonella spp., E. coli O157:H7, L. monocytogenes, V. parahaemolyticus, Y. enterocolitica를 실험한 결과 약수와 음용도구에서 Y. enterocolitica 등 6종의 식중독 미생물은 검출되지 않았으나, B. cereus는 음용 도구 34건 중 5건 (14.7%) 검출되었다. 약수터 음용도구에서 분리된 B. cereus의 주요 설사독소 유전자는 nheA와 entFM로 나타났다. B. cereus 5균주는 모두 NHE 설사 독소를 생산하였으나 HBL은 2균주에서만 검출되었다. 항생제 감수성 실험결과 oxacillin 등 ${\beta}-lactam$계 항생제에 내성을 나타내었다. 약수터 음용도구의 미생물 오염도와 분리된 B. cereus의 독소 유전자 및 독소 단백질 생산능을 분석한 결과 약수터에 비치된 음용도구에 의한 식중독 위험성이 상존하는 것으로 나타났다. 따라서 다중이 사용하는 약수터 음용도구의 철저한 위생관리가 필요하며 위생관리가 곤란할 경우 개인 컵을 이용하거나 미생물 안전성을 확보할 수 있는 음용도구 개발이 필요한 것으로 판단되었다.

• Nutrition Research and Practice
• /
• 제11권5호
• /
• pp.373-380
• /
• 2017

BACKGROUND/OBJECTIVES: This study was conducted to investigate the effect of a corn silk extract on improving benign prostatic hyperplasia (BPH). MATERIALS/METHODS: The experimental animals, 6-week-old male Wistar rats, were divided into sham-operated control (Sham) and experimental groups. The experimental group, which underwent orchiectomy and received subcutaneous injection of 10 mg/kg of testosterone propionate to induce BPH, was divided into a Testo Only group that received only testosterone, a Testo+Fina group that received testosterone and 5 mg/kg finasteride, a Testo+CSE10 group that received testosterone and 10 mg/kg of corn silk extract, and a Testo+CSE100 group that received testosterone and 100 mg/kg of corn silk extract. Prostate weight and concentrations of dihydrotestosterone (DHT), $5{\alpha}$- reductase $2(5{\alpha}-R2)$, and prostate specific antigen (PSA) in serum or prostate tissue were determined. The mRNA expressions of $(5{\alpha}-R2)$ and proliferating cell nuclear antigen (PCNA) in prostate tissue were also measured. RESULTS: Compared to the Sham group, prostate weight was significantly higher in the Testo Only group and decreased significantly in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups (P < 0.05), results that were consistent with those for serum DHT concentrations. The concentrations of $(5{\alpha}-R2)$ in serum and prostate as well as the mRNA expression of $(5{\alpha}-R2)$ in prostate were significantly lower in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups than that in the Testo Only group (P < 0.05). Similarly, the concentrations of PSA in serum and prostate were significantly lower in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups (P < 0.05) than in the Testo Only group. The mRNA expression of PCNA in prostate dose-independently decreased in the Testo+CSE-treated groups (P < 0.05). CONCLUSIONS: BPH was induced through injection of testosterone, and corn silk extract treatment improved BPH symptoms by inhibiting the mRNA expression of $(5{\alpha}-R2)$ and decreasing the amount of $(5{\alpha}-R2)$, DHT, and PSA in serum and prostate tissue.

• 대한화장품학회지
• /
• 제43권1호
• /
• pp.19-26
• /
• 2017

본 연구에서는 채진목의 항염증 효과를 알아보기 위하여 LPS로 염증을 유도한 RAW 264.7 세포에 대한 채진목 70% 에탄올 추출물의 효과를 살펴보았다. 채진목 70% 에탄올 추출물의 대식세포에서의 세포 독성 측정을 MTT assay를 수행하였다. 세포 독성을 측정한 결과, $1,000{\mu}g/mL$의 농도에서 96%의 세포 생존율을 나타내었다. 항염증 활성을 효과적으로 검증하기 위해, LPS로 유도된 대식세포 내 NO 생산을 억제하는 효과를 Griess의 방법으로 조사하였다. 그 결과, 채진목 70% 에탄올 추출물에서 NO의 생성이 농도 의존적으로 저해되었음을 확인하였다. 채진목 70% 에탄올 추출물을 western blot을 이용하여 단백질 발현을 측정한 결과 처리한 세포군에서 농도가 증가함에 따라 iNOS와 COX-2의 단백질 발현양이 감소하여 최고 농도인 $500{\mu}g/mL$에서 각각 84.3%, 56.2%의 발현 억제를 보여주었다. Reverse transcription-polymerase chain reaction (RT-PCR)을 통하여 mRNA 발현양을 측정한 결과 iNOS와 COX-2의 mRNA 발현양이 감소하여 $500{\mu}g/mL$ 농도에서 89.8%, 84.9%로 나타내었다. 이러한 결과로 보아 채진목 70% 에탄올 추출물의 항염증에 관한 그 효능을 확인할 수 있었고, 따라서 채진목 70% 에탄올 추출물이 천연 항염증 소재로써 가능성이 있다고 판단된다.

• 한국병원경영학회지
• /
• 제23권3호
• /
• pp.28-38
• /
• 2018

Purposes: 본 연구는 전립선암 환자의 의료비 지출을 평가하기 위해 남성호르몬 박탈 치료와 근치적 전립선적출술의 비용을 비교하였다. Methods: 본 연구는 스마트 전립선암 데이터베이스(Smart Prostate Cancer Database)의 전립선암 환자 357명의 데이터와 청구데이터베이스에서 의료비 관련 데이터를 도출하였다. 근치적 전립선적출술과 남성호르몬 박탈 치료간 비교를 위해 독립표본 t검정을 실시하였다. 또한 남성호르몬 박탈 치료와 근치적 전립선적출술에 영향을 미치는 요인을 검증하기 위해 다중회귀 분석을 실시하였다. Findings: 치료 후 1년까지 남성호르몬 박탈치료가 근치적 전립선적출술 보다 비용이 낮은 것으로 나타났으며, 치료 후 4년까지 낮게 유지되었다. 그러나 4년이 지나면 남성호르몬 박탈 치료의 누적의료비가 근치적 전립선적출술보다 더 유의미하게 높게 나타났다. 환자의 병기가 높거나 나이가 많은 경우 근치적 전립선적출술보다 남성호르몬 박탈 치료를 할 확률이 더 높았다. Practical Implications: 본 연구는 조기 암 발견이 환자 뿐 아니라 국민건강보험공단의 의료비를 줄일 수 있다는 것을 보여 준다. 또한 의료비를 정확히 평가하기 위해서는 오랜 기간의 정보를 평가해야 하며, 이를 기반으로 평가 및 예측이 필요함을 증명하였다.